Vaccine against SARS-CoV-2: Challenges and considerations
It is essential to consider challenges previously faced and addressed while developing a vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Considering the severity of the health crisis that SARS-CoV-2 has caused worldwide, and with so little known about the virus, our foc...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Health Agency of Canada
2021-03-01
|
| Series: | Canada Communicable Disease Report |
| Subjects: | |
| Online Access: | https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-3-march-2021/sars-cov-2-vaccine-challenges-considerations.html |